PeptideDB

Loureirin C

CAS No.: 116384-24-8

Loureirin C can inhibit the activities of thrombin in vitro effectively.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Loureirin C can inhibit the activities of thrombin in vitro effectively.
In vitro Dragon's blood is the name given to a deep red resin obtained from a variety of plant sources. The resin extracted from stems of Dracaena cochinchinensis is one such source of 'dragon's blood'. It has a reputation for facilitating blood circulation and dispersing blood stasis. In traditional Chinese medicine, this resinous medicine is commonly prescribed to invigorate blood circulation for the treatment of traumatic injuries, blood stasis and pain. Modern pharmacological studies have found that this resinous medicine has anti-bacterial, anti-spasmodic, anti-inflammatory, analgesic, anti-diabetic, and anti-tumor activities, while it is also known to enhance immune function, promote skin repair, stop bleeding and enhance blood circulation. Various compounds have been isolated from the plant, including loureirin A, loureirin B, Loureirin C, cochinchinenin, socotrin-4'-ol, 4',7-dihydroxyflavan, 4-methylcholest-7-ene-3-ol, ethylparaben, resveratrol, and hydroxyphenol[1]
Synonyms 龙血素C, 龙血素 C
molecular weight 272.3
Molecular formula C16H16O4
CAS 116384-24-8
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 65 mg/mL (238.71 mM)
References 1. A Systematic Review of the Botanical, Phytochemical and Pharmacological Profile of Dracaena cochinchinensis, a Plant Source of the Ethnomedicine "Dragon's Blood".Molecules, 2014, 19(7):10650-10669.